Affinity Asset Advisors
BOLD icon

Affinity Asset Advisors’s Boundless Bio BOLD Stock Holding History

Affinity Asset Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-250,000
Closed -$625K – 141
2026
Q2 		$625K Buy
+250,000
New +$385K 0.03% 107

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
RBF Capital
RBF Capital San Francisco, California $2.3B AUM 22.6% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Affinity Asset Advisors's BOLD Position: Q3 2026 in Review

Affinity Asset Advisors sold out of Boundless Bio (BOLD) in Q3 2026, closing a stake of 250,000 shares — an estimated $625K sold.

Affinity Asset Advisors first reported a position in BOLD in Q2 2026 and held it in 1 quarter. The position peaked at $625K in Q2 2026. 25 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • Affinity Asset Advisors reported no remaining Boundless Bio position as of Q3 2026 after selling out during the quarter.
  • Affinity Asset Advisors sold 250,000 Boundless Bio shares in Q3 2026, an estimated $625K.
  • Affinity Asset Advisors first reported a position in Boundless Bio in Q2 2026 and held it in 1 quarter.
  • Affinity Asset Advisors's Boundless Bio position peaked at $625K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.